• Home
  • About GPCRCentral

GPCR News

Entries RSS | Comments RSS
  • Tags

    5-HT1A 5-HT2 5-HT2A 5-HT3 5-HT4 5-ht6 5HT1A 5HT1D 5HT2 5HT2A 5HT3 5HT4 5ht6 agonist Angiotensin II AT1 antagonist Astrazeneca Beta 2 adrenoceptor Cannabinoid CB1 Daiichi-Sankyo Dopamine Dopamine D2 Fentanyl ghrelin GlaxoSmithkline GLP-1 gpcr GSK Histamine H1 Licensing Lilly Merck Muscarinic Opioid Opioid mu phase I phase II phase III Preclinical regulatory Research Sanofi-Aventis TRPV1 Vanilloid
  •  

    June 2008
    M T W T F S S
    « May   Jul »
     1
    2345678
    9101112131415
    16171819202122
    23242526272829
    30  

Angiotensin II receptor antagonists slow rate of progressive aortic-root dilation in Marfans

Posted on June 26, 2008 by crimsoncanary

Data published in this weeks NEJM show that angiotensin II receptor antagonists delay the progression of aortic root dissection in patients with Marfan’s syndrome

Filed under: Uncategorized | Tagged: Angiotensin II AT1, antagonist, Aprovel, Avapro, Avastar, BMS, BMS-186295, BMS186295, BMS741672, Cosaar, Cozaar, Cozaarex, Dainippon Sumitomo, DuP-753, E-3340, Ex-89, EXP-3174, Irban, Irbesartan, Irbetan, Karvea, Lorzaar, losartan, MK-954, Newlotan, Nu-Lotan, Ocsaar, Paxon, Sanofi-Aventis, Shionogi, SR-47436, SR47436

« Modulating αlpha2-Adrenoreceptor antagonists in to agosnists Vandas Tasimelteon (VEC-162) Improves Sleep in Patients with Chronic Insomnia »

Leave a Reply

Click here to cancel reply.

  • Calendar

    • June 2008
      M T W T F S S
      « May   Jul »
       1
      2345678
      9101112131415
      16171819202122
      23242526272829
      30  
  • Blogroll

    • CrimsonCanary.com
    • GPCRCentral.com
    • IonChannelCentral.com
    • Kinasecentral.com
    • Pharma Company Pipelines

Blog at WordPress.com. Theme: Digg 3 Column by WP Designer